Financial reports
10-Q
2023 Q3
Quarterly report
8 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
10-Q
2023 Q1
Quarterly report
15 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
28 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
10-K
2021 FY
Annual report
29 Mar 22
10-Q
2021 Q3
Quarterly report
15 Nov 21
Current reports
8-K
Completion of Acquisition or Disposition of Assets
5 Jan 24
8-K
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting “FOR” Pending Merger with Standard BioTools
2 Jan 24
8-K
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
29 Dec 23
8-K
Regulation FD Disclosure
29 Dec 23
8-K
SomaLogic Issues Statement Correcting Madryn Asset Management’s Misleading Disclosure
26 Dec 23
8-K
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools
22 Dec 23
8-K
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools
21 Dec 23
8-K
Departure of Directors or Certain Officers
12 Dec 23
8-K
Standard BioTools Activating Strategy to Become a Diversified Leader in Life Sciences Tools NOVEMBER 2023
28 Nov 23
8-K
Other Events
21 Nov 23
Registration and prospectus
15-12G
Securities registration termination
16 Jan 24
POS AM
Prospectus update (post-effective amendment)
5 Jan 24
POS AM
Prospectus update (post-effective amendment)
5 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jan 24
S-8 POS
Registration of securities for employees (post-effective amendment)
5 Jan 24
25-NSE
Exchange delisting
5 Jan 24
425
Business combination disclosure
29 Dec 23
425
Business combination disclosure
26 Dec 23
425
Business combination disclosure
22 Dec 23
Proxies
DFAN14A
Additional proxy materials by non-management
5 Jan 24
DFAN14A
Additional proxy materials by non-management
4 Jan 24
DFAN14A
Additional proxy materials by non-management
4 Jan 24
DFAN14A
Additional proxy materials by non-management
3 Jan 24
DEFA14A
Additional proxy soliciting materials
2 Jan 24
DFAN14A
Additional proxy materials by non-management
2 Jan 24
DEFA14A
Additional proxy soliciting materials
2 Jan 24
DFAN14A
Additional proxy materials by non-management
2 Jan 24
DEFA14A
Additional proxy soliciting materials
29 Dec 23
DEFA14A
Additional proxy soliciting materials
29 Dec 23
Other
EFFECT
Notice of effectiveness
12 Jan 24
EFFECT
Notice of effectiveness
12 Jan 24
EFFECT
Notice of effectiveness
3 May 23
EFFECT
Notice of effectiveness
18 Nov 22
CORRESP
Correspondence with SEC
15 Nov 22
UPLOAD
Letter from SEC
4 Nov 22
CT ORDER
Confidential treatment order
19 Oct 22
EFFECT
Notice of effectiveness
19 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22
CORRESP
Correspondence with SEC
17 Oct 22